261 related articles for article (PubMed ID: 14619320)
1. Dermatology clinical trials and drug development.
Ehrenberger HE; Joshi TG
Dermatol Nurs; 2003 Oct; 15(5):428-34. PubMed ID: 14619320
[No Abstract] [Full Text] [Related]
2. A proposal for radical changes in the drug-approval process.
Wood AJ
N Engl J Med; 2006 Aug; 355(6):618-23. PubMed ID: 16899784
[No Abstract] [Full Text] [Related]
3. Mega issues: focusing on the future of dermatology nursing.
DNA Board of Directors
Dermatol Nurs; 2004 Apr; 16(2):138, 147-8. PubMed ID: 15148897
[TBL] [Abstract][Full Text] [Related]
4. Dermatology nursing: spreading good practice in primary care.
Barrett C
J Fam Health Care; 2005; 15(2):35. PubMed ID: 15945491
[No Abstract] [Full Text] [Related]
5. Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials.
Garmendia CA; Nassar Gorra L; Rodriguez AL; Trepka MJ; Veledar E; Madhivanan P
JAMA Intern Med; 2019 Apr; 179(4):582-584. PubMed ID: 30830216
[TBL] [Abstract][Full Text] [Related]
6. Conflating the approval process and clinical research with pharmacoeconomic evaluation.
Somberg JC
Am J Ther; 2013 Jan; 20(1):1. PubMed ID: 23299228
[No Abstract] [Full Text] [Related]
7. The FDA and IBS drug development.
Mangel AW
Am J Gastroenterol; 2009 Dec; 104(12):3106; author reply 3106. PubMed ID: 19956135
[No Abstract] [Full Text] [Related]
8. FDA introductory comments: clinical studies design and evaluation issues.
Woodcock J
Clin Trials; 2005; 2(4):273-5. PubMed ID: 16281424
[No Abstract] [Full Text] [Related]
9. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia.
Talley NJ
Am J Gastroenterol; 2009 Jun; 104(6):1339-41. PubMed ID: 19491845
[No Abstract] [Full Text] [Related]
10. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
11. Research activity and evidence-based practice within DNA: a survey.
Ersser SJ; Plauntz L; Sibley A
Dermatol Nurs; 2008 Jun; 20(3):189-94. PubMed ID: 18649703
[TBL] [Abstract][Full Text] [Related]
12. The development of a standardized dermatology residency program for the clinical doctorate in advanced nursing.
Shelby D
Dermatol Nurs; 2008 Dec; 20(6):437-47: quiz 438. PubMed ID: 19241739
[TBL] [Abstract][Full Text] [Related]
13. [Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical anti-acne].
Verschoore M; Poncet M; Schaefer H; Revuz J; De Prost Y; Guillaume JC; Ortonne JP; Czernielewski J
Therapie; 1991; 46(3):189-91. PubMed ID: 1838841
[TBL] [Abstract][Full Text] [Related]
14. Communicating with the FDA: the "third rail" of a new model for drug development.
Stanski DR; Orloff JJ
J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
[No Abstract] [Full Text] [Related]
15. Generic drugs--safe, effective, and affordable.
Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
[TBL] [Abstract][Full Text] [Related]
16. They are from the government and they really are here to help you.
Woosley RL
J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
[No Abstract] [Full Text] [Related]
17. Comparative assessment for medications and devices: apples and oranges?
Ramsey S
Value Health; 2010 Jun; 13 Suppl 1():S12-4. PubMed ID: 20618788
[No Abstract] [Full Text] [Related]
18. Clinical trials in the wake of Vioxx: requiring statistically extreme evidence of benefit to ensure the safety of new drugs.
Roth-Cline MD
Circulation; 2006 May; 113(18):2253-9. PubMed ID: 16684875
[No Abstract] [Full Text] [Related]
19. Uneasy alliance--clinical investigators and the pharmaceutical industry.
Bodenheimer T
N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
[No Abstract] [Full Text] [Related]
20. The special treatment.
Osborne R
Nat Biotechnol; 2008 May; 26(5):487-9. PubMed ID: 18464770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
